Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
KemNet logo — KemNet – A Division of Kemet Group | Personalized Medicine |...

KemNet

KemNet – A Division of Kemet Group | Personalized Medicine | Innovating Pharmacy Technology | Resolving Drug Shortages

Founded 2022 Canada Edmonton, Canada 1 employees Pre-Seed Total: $500.00K B2B, Health and Wellness +1

General Information

Company Name KemNet
Founded Year 2022
Location Canada Edmonton, Canada
Founders / Decision Makers
Team member
Employees 1
Industries B2B, Health and Wellness, Pharmaceutical
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with KemNet. To contact KemNet, visit kemet.care.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does KemNet compare?

A PDF of KemNet and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting KemNet soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About KemNet

🌐 KemNet, a visionary division of Kemet Group Inc., is at the forefront of healthcare technology innovation. We specialize in creating cutting-edge software solutions that are reshaping the pharmaceutical landscape in Alberta and beyond. 🔍 Our Mission: Our mission is to streamline the process of ordering compounded medications for pharmacies, ensuring efficiency, transparency, and compliance with regulatory standards. At KemNet, we believe in leveraging technology to facilitate seamless interactions between pharmacies and compounding labs, while maintaining the highest levels of ethical practice and patient safety. 💊 Innovative Solutions for Modern Pharmacy Challenges: KemNet's platform not only simplifies medication ordering but also addresses critical challenges such as drug shortages. Over time our advanced monitoring and resolution capabilities will demonstrate our commitment to providing proactive solutions in the pharmaceutical industry. 🔐 Ensuring Compliance and Transparency: We prioritize transparency and compliance, that will enable pharmacies to maintain a clear regulatory and third-party insurance audit trail. This approach reflects our dedication to upholding the integrity of pharmaceutical operations. 🌍 A Future-Focused Approach: Under the dynamic leadership of our CEO - Morẹ́nikẹ́ Ẹniọlá Ọláòṣebìkan, KemNet is not just a software platform; it's a movement towards a more efficient, responsible, and patient-centered pharmaceutical ecosystem. Join us on our journey as we continue to innovate and lead in the realm of pharmacy technology. 🔗 https://kemet.care/ #MakeYourMedicine #MedicineForYouByYou #HealthcareTechnology #PharmacyInnovation #DigitalHealthcare #ComplianceSolutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $500.00K 1
Y Combinator
Y Combinator
22 Aug 2022

FAQ About KemNet

KemNet – A Division of Kemet Group | Personalized Medicine | Innovating Pharmacy Technology | Resolving Drug Shortages
KemNet was founded in 2022.
KemNet is headquartered in Edmonton, Canada.
KemNet operates in B2B, Health and Wellness and Pharmaceutical.
KemNet has approximately 1 employees.
KemNet has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Pre-Seed.

We're actively collecting intelligence on KemNet.

Source: BounceWatch company record for KemNet, https://bouncewatch.com/company/kemnet, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout